pI: 9.1326 |
Length (AA): 305 |
MW (Da): 33848 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128038)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G30160 | mitochondrial substrate carrier family protein |
Arabidopsis thaliana | AT1G07030 | mitochondrial substrate carrier family protein |
Babesia bovis | BBOV_II006420 | Mitochondrial carrier protein, putative |
Brugia malayi | Bm1_01565 | Mitochondrial carrier protein |
Candida albicans | CaO19.2178 | likely mitochondrial carrier protein similar to S. cerevisiae MRS3 (YJL133W) and MRS4 (YKR052C) mitochondrial iron transporters |
Candida albicans | CaO19.9724 | likely mitochondrial carrier protein similar to S. cerevisiae MRS3 (YJL133W) and MRS4 (YKR052C) mitochondrial iron transporters |
Caenorhabditis elegans | CELE_W02B12.9 | Protein MFN-1 |
Cryptosporidium hominis | Chro.20115 | mitochondrial carrier protein |
Cryptosporidium parvum | cgd2_1030 | mitochondrial carrier protein, putative |
Dictyostelium discoideum | DDB_G0269470 | mitochondrial substrate carrier family protein |
Drosophila melanogaster | Dmel_CG4963 | mitoferrin |
Echinococcus granulosus | EgrG_000793300 | mitoferrin 1 |
Echinococcus multilocularis | EmuJ_000793300 | mitoferrin 1 |
Homo sapiens | 51312 | solute carrier family 25 (mitochondrial iron transporter), member 37 |
Homo sapiens | ENSG00000155287 | solute carrier family 25 (mitochondrial iron transporter), member 28 |
Leishmania braziliensis | LbrM.29.2840 | mitochondrial carrier protein-like protein |
Leishmania donovani | LdBPK_292890.1 | mitochondrial carrier protein-like protein |
Leishmania infantum | LinJ.29.2890 | mitochondrial carrier protein-like protein |
Leishmania major | LmjF.29.2780 | mitochondrial carrier protein-like protein |
Leishmania mexicana | LmxM.08_29.2780 | mitochondrial carrier protein-like protein |
Mus musculus | ENSMUSG00000034248 | solute carrier family 25, member 37 |
Mus musculus | ensembl-mmu:ENSMUSG00000040414 | solute carrier family 25, member 28 |
Neospora caninum | NCLIV_068510 | hypothetical protein |
Oryza sativa | 4332542 | Os03g0296800 |
Saccharomyces cerevisiae | YJL133W | Mrs3p |
Saccharomyces cerevisiae | YKR052C | Mrs4p |
Schistosoma japonicum | Sjp_0061630 | ko:K03454 mitochondrial carrier protein, MC family, putative |
Schistosoma mansoni | Smp_055190 | mitochondrial solute carrier-related |
Schmidtea mediterranea | mk4.000610.00 | Mitoferrin |
Schmidtea mediterranea | mk4.000610.02 | Mitoferrin |
Schmidtea mediterranea | mk4.010564.01 | Mitoferrin |
Schmidtea mediterranea | mk4.054699.00 | Mitoferrin |
Trypanosoma brucei gambiense | Tbg972.3.3060 | mitochondrial carrier protein, putative |
Trypanosoma brucei | Tb927.3.2980 | mitochondrial carrier protein |
Trypanosoma congolense | TcIL3000_3_1890 | mitochondrial carrier protein, putative |
Trypanosoma cruzi | TcCLB.510315.20 | mitochondrial carrier protein, putative |
Trypanosoma cruzi | TcCLB.508153.630 | mitochondrial carrier protein, putative |
Toxoplasma gondii | TGME49_277090 | carrier superfamily protein |
Theileria parva | TP02_0605 | mitochondrial solute carrier protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.2980 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.2980 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.2980 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.3.2980 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_W02B12.9 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_W02B12.9 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_277090 | Toxoplasma gondii | Probably essential | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.